HOMEVULNERABILITIESCVE-2026-27360
MEDIUM

CVE-2026-27360

CWE-79Published: February 19, 2026· Updated: Feb 20, 2026

5.9
CVSS v3.1
EPSS:0.03%probability of exploitation in 30 daysPercentile:8.8th

Official Description

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in 10Web Photo Gallery by 10Web photo-gallery allows Stored XSS.This issue affects Photo Gallery by 10Web: from n/a through <= 1.8.37.

NVD Source

Technical Analysis

CVE-2026-27360 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

Exploitation requires high privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

The vulnerability has a "Changed" scope, meaning successful exploitation can impact components beyond the vulnerable component itself — such as the host operating system or adjacent services.

From a weakness classification perspective (CWE-79): Cross-site scripting (XSS) vulnerabilities allow attackers to inject malicious scripts into web pages viewed by other users.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.High
User InteractionRequired
ScopeChanged
Impact
ConfidentialityLow
IntegrityLow
AvailabilityLow
CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:C/C:L/I:L/A:L

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

All References (1)

Quick Facts

CVE IDCVE-2026-27360
CVSS Score5.9 / 10
SeverityMEDIUM
WeaknessCWE-79
CISA KEVNo
EPSS (30d)0.03%
PublishedFeb 19, 2026

Related CVEs (CWE-79)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2026-27360 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.